Contents
Download PDF
pdf Download XML
918114 Views
18473 Downloads
Share this article
Research Article | Volume 15 Issue 1 (, 2009) | Pages 28 - 33
Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis
 ,
 ,
 ,
 ,
 ,
1
Cardiology Unit, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Adelaide, S.A., Australia.
Under a Creative Commons license
PMID : -16480009
Published
Jan. 19, 2006
Abstract

Background and aim of the study: Patients with aortic stenosis (AS) exhibit increased platelet aggregability, and thrombus formation has been documented on calcific and severely stenosed valves. Isolated porcine and canine aortic valves (AV) release nitric oxide (NO) and prostacyclin, which exert local antithrombotic effects; to date, this has not been studied in humans. In the present study the possible interaction of AV tissue with platelet aggregation was examined, using fragments of AV obtained from patients with AS and aortic regurgitation (AR).

Methods: Fragments of AV tissue, excised from patients undergoing AV replacement, were co-incubated with blood samples obtained from normal subjects. The direct effects of valve tissue from patients with AS (n = 14) or with predominant AR (n = 13) on ADP-induced platelet aggregation and intraplatelet cGMP and cAMP content were compared.

Results: In whole blood, non-calcified AV fragments from AR patients inhibited platelet aggregation by 57 +/- 6% (p < 0.01); in platelet-rich plasma results were analogous. In order to determine whether this anti-aggregatory effect could be attributed to the valvular release of NO or prostacyclin, intraplatelet cGMP and cAMP formation was assessed, respectively. While there were no significant changes in cGMP content, cAMP increased by 26 +/- 4% (p < 0.02). Both, anti-aggregatory and cAMP-stimulating effects were similar to those produced by 10 nM prostaglandin E1, a prostacyclin mimetic. Fragments from stenotic valves did not inhibit aggregation and did not affect cGMP or cAMP. Furthermore, fragments from heavily calcified regions potentiated aggregation and, in some cases, induced spontaneous aggregation.

Conclusion: Minimally calcified aortic valves (i.e., AR) and, therefore, presumably also normal valves, exert anti-aggregatory effects, most likely via prostacyclin release. AS is associated with a loss of this effect, thus potentially contributing to thrombotic risk.

 

 

 

How to cite: Chirkov YY, Mishra K, Chandy S, Holmes AS, Kanna R, Horowitz JD. Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis. J Heart Valve Dis. 2006 Jan;15(1):28-33. PMID: 16480009.

Keywords
Recommended Articles
Research Article
To evaluate the usefulness of echocardiographic variables in predicting response of vasodilator therapy in patients of congenital heart disease patients with pulmonary arterial hypertension
...
Published: 29/12/2025
Download PDF
Read Article
Research Article
Evaluation of Microstructural Changes in Postencephalitic Patients with Memory Dysfunction Using Diffusion Tensor Imaging
Published: 28/06/2025
Download PDF
Read Article
Research Article
To study Lipid Profile Alterations in Young Adults with Sedentary Lifestyle
...
Published: 22/05/2025
Download PDF
Read Article
Research Article
Comparative assessment of coagulation factors in patients of mitral stenosis with inactive left atrial appendage in sinus rhythm versus atrial fibrillation
...
Published: 28/11/2025
Download PDF
Read Article
Chat on WhatsApp
© Copyright Journal of Heart Valve Disease